Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pane

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
British Journal of Haematology|April 3, 2025
Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre studyC Giordano, M Picardi, N Pugliese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Differences among young adults, adults and elderly chronic myeloid leukemia patientsF Castagnetti, G Gugliotta, M Baccarani, et al.
Leukemia|June 20, 2015
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinibF Castagnetti, G Gugliotta, M Breccia, et al.
Leukemia|October 17, 2003
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer programJ Gabert, E Beillard, V H J van der Velden, et al.
Leukemia|October 3, 2002
Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemiaM Mancini, M L Vegna, G L Castoldi, et al.
Hematological Oncology|November 18, 2024
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life StudyM Picardi, A Vincenzi, C Giordano, et al.
Leukemia|March 5, 2020
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemiaA Hochhaus, M Baccarani, R T Silver, et al.
La Radiologia Medica|October 28, 2008
Indications for breast magnetic resonance imaging. Consensus document "Attualità in senologia", Florence 2007F Sardanelli, G M Giuseppetti, G Canavese, et al.
Leukemia|January 16, 2020
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Leukemia|March 13, 2019
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
British Journal of Haematology|April 3, 2025
Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre studyC Giordano, M Picardi, N Pugliese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Differences among young adults, adults and elderly chronic myeloid leukemia patientsF Castagnetti, G Gugliotta, M Baccarani, et al.
Leukemia|June 20, 2015
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinibF Castagnetti, G Gugliotta, M Breccia, et al.
Leukemia|October 17, 2003
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer programJ Gabert, E Beillard, V H J van der Velden, et al.
Leukemia|October 3, 2002
Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemiaM Mancini, M L Vegna, G L Castoldi, et al.
Hematological Oncology|November 18, 2024
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life StudyM Picardi, A Vincenzi, C Giordano, et al.
Leukemia|March 5, 2020
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemiaA Hochhaus, M Baccarani, R T Silver, et al.
La Radiologia Medica|October 28, 2008
Indications for breast magnetic resonance imaging. Consensus document "Attualità in senologia", Florence 2007F Sardanelli, G M Giuseppetti, G Canavese, et al.
Leukemia|January 16, 2020
Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Leukemia|March 13, 2019
Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.
Pageof 9